Plain-English translation of NCT06461767 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called Repetitive Transcranial Magnetic Stimulation (rTMS) for chronic migraines. rTMS uses magnetic pulses applied to your scalp to stimulate specific areas of your brain. The researchers want to find out if this treatment can reduce how often you get migraines and how severe they are.
Chronic migraines cause much worse quality of life and greater disability compared to occasional migraines, and many patients need better treatment options. This trial is exploring whether the medication can help patients who haven't been able to use other preventive treatments recently.
You would receive magnetic stimulation sessions applied to your scalp over one of several brain areas (or sham/placebo stimulation for comparison). The magnetic coil is placed against your head, and brief pulses are delivered to stimulate brain regions that may help with migraine control. You would attend regular visits to monitor how your migraines respond to the treatment.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Egypt
Sohag University
Enrollment target
~60 participants
Started
January 2024
Primary completion
January 2025
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tarek Mohamed
Sohag faculty of medicine